Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07563881
PHASE3

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

Sponsor: Rapport Therapeutics Inc.

View on ClinicalTrials.gov

Summary

This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.

Official title: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

333

Start Date

2026-06-05

Completion Date

2029-09

Last Updated

2026-11-16

Healthy Volunteers

No

Interventions

DRUG

RAP-219

RAP-219 high dose tablets administered orally daily

DRUG

RAP-219

RAP-219 medium dose tablets administered orally daily

OTHER

Placebo

Matching placebo tablets administered orally daily

Locations (24)

Clinical Study Center

Birmingham, Alabama, United States

Clinical Study Center

Palmdale, California, United States

Clinical Study Center

San Francisco, California, United States

Clinical Study Center

Gulf Breeze, Florida, United States

Clinical Study Center

Atlanta, Georgia, United States

Clinical Study Center

Boise, Idaho, United States

Clinical Study Center

Springfield, Illinois, United States

Clinical Study Center

Fort Wayne, Indiana, United States

Clinical Study Center

Bethesda, Maryland, United States

Clinical Study Center

Hackensack, New Jersey, United States

Clinical Study Center

Livingston, New Jersey, United States

Clinical Study Center

New York, New York, United States

Clinical Study Center

The Bronx, New York, United States

Clinical Study Center

Asheville, North Carolina, United States

Clinical Study Center

Cleveland, Ohio, United States

Clinical Study Center

Philadelphia, Pennsylvania, United States

Clinical Study Center

Richmond, Virginia, United States

Clinical Study Center

Melbourne, Australia

Clinical Study Center

Sydney, Australia

Clinical Study Center

Busan, Republic of Korea, South Korea

Clinical Study Center

Seoul, Republic of Korea, South Korea

Clinical Study Center

Seoul, Republic of Korea, South Korea

Clinical Study Center

Seoul, South Korea

Clinical Study Center

Plymouth, United Kingdom